Shandong Huashang Chemical Co., Ltd.
Product
3-bromo-1H-indazole-7-carbonitrile
  • Brand:HuaShang
  • Model:25kg/drum
  • Purity:99%
  • Cas:945762-00-5
  • Createtime: 2026-04-14
  • Updatetime: 2026-04-15
Product Details
Boiling Point 425.3 ± 25.0 °C
useage Industrial use
deliveryInfo
appearance Off-white to light brown crystalline powder
Stability Stable under inert atmosphere; sensitive to strong acids, strong bases, and oxidizing agents
Storage Condition Sealed under nitrogen/argon at 2–8 °C; avoid light and moisture
aliasen
supplyCapacity 50000Metric Ton/Month
Solubility Very slightly soluble in water (0.18 g/L, 25 °C); soluble in DMSO, DMF, and hot organic solvents
harbor Qingdao,China
minorder 1KG
  1. Appearance: Off-white to light brown crystalline powder
  2. Purity (HPLC): ≥95.0% (typically 98.0%)
  3. Melting Point: 188–192 °C
  4. Water Content (KF): ≤0.5%
  5. Residue on Ignition: ≤0.1%
  6. Heavy Metals (Pb): ≤10 ppm
  7. Assay: 95.0–105.0%


Applications

3-Bromo-1H-indazole-7-carbonitrile is a high-value heterocyclic building block and a potent neuronal nitric oxide synthase (nNOS) inhibitor, widely used in pharmaceutical R&D and organic synthesis. As a key intermediate, it enables the construction of diverse indazole-based derivatives, particularly in the development of NOS inhibitors, anticancer agents, and neuroprotective drugs. Its unique structure—featuring a bromine at C3 and a cyano group at C7—allows for selective functionalization via cross-coupling reactions (e.g., Suzuki, Buchwald) and nucleophilic substitution, making it indispensable for synthesizing complex bioactive molecules. In pharmacological research, it serves as a tool compound to study NO-mediated signaling pathways, with IC50 values of 2.5 μM (nNOS), 5.7 μM (iNOS), and 13 μM (eNOS), supporting investigations into neurodegenerative diseases, inflammation, and pain mechanisms. Additionally, it is employed in biochemical assays and as a reference standard for analytical method development, catering to the growing demand for targeted therapeutics in the biopharmaceutical industry.

Safety Information

This compound is classified as a GHS Warning substance with moderate acute toxicity and irritant properties. Hazard Statements: H302 (Harmful if swallowed), H315 (Causes skin irritation), H319 (Causes serious eye irritation), H335 (May cause respiratory irritation). Inhalation of dust may trigger coughing, throat irritation, or shortness of breath; thus, work areas require adequate ventilation, and N95 respirators are recommended during handling. Skin contact may cause redness, itching, or dermatitis; protective gloves and lab coats must be worn, and affected skin should be rinsed thoroughly with soap and water post-exposure. Eye exposure can result in severe irritation, tearing, or corneal damage; immediate flushing with copious water for ≥15 minutes is critical, with prompt medical attention if symptoms persist. Ingestion may lead to nausea, vomiting, abdominal pain, or diarrhea; accidental ingestion requires drinking 2–3 glasses of water and seeking medical advice. The compound is non-flammable but may emit toxic NO? and bromide fumes when heated to decomposition. Store separately from oxidants, strong acids, and foodstuffs; contain spills with inert absorbents and dispose of waste per local hazardous material regulations.